|
|
|
|
| LEADER |
04954cam a2200805Ia 4500 |
| 001 |
228148477 |
| 003 |
OCoLC |
| 005 |
20180526100210.9 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
080516s2008 ne a ob 001 0 eng d |
| 019 |
|
|
|a 213382013
|a 441820124
|a 647894767
|
| 020 |
|
|
|a 9780123739834
|
| 020 |
|
|
|a 0123739837
|
| 020 |
|
|
|a 9780080561035
|q (electronic bk.)
|
| 020 |
|
|
|a 0080561039
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)228148477
|z (OCoLC)213382013
|z (OCoLC)441820124
|z (OCoLC)647894767
|
| 037 |
|
|
|a 137678:137815
|b Elsevier Science & Technology
|n http://www.sciencedirect.com
|
| 040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d OCLCQ
|d N$T
|d CDX
|d MERUC
|d YDXCP
|d E7B
|d IDEBK
|d OCLCQ
|d REDDC
|d OCLCQ
|d OCLCF
|d CHVBK
|d OCLCQ
|d BUF
|d OCLCO
|
| 049 |
|
|
|a COM6
|
| 050 |
|
4 |
|a QP552.T68
|b L38 2008eb
|
| 060 |
|
4 |
|a 2008 A-369
|
| 060 |
|
4 |
|a QU 475
|b L351e 2008
|
| 070 |
|
|
|a QP552.T68
|b L38 2008
|
| 072 |
|
7 |
|a SCI
|x 049000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 572.8/845
|2 22
|
| 100 |
1 |
|
|a Latchman, David S.
|
| 245 |
1 |
0 |
|a Eukaryotic transcription factors /
|c David S. Latchman.
|
| 250 |
|
|
|a 5th ed.
|
| 264 |
|
1 |
|a Amsterdam ;
|a Boston :
|b Elsevier/Academic Press,
|c 2008.
|
| 300 |
|
|
|a 1 online resource (xxviii, 471 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 520 |
|
|
|a Transcription, or the process by which DNA produces RNA, is a central aspect of gene expression. Transcription factors regulate transcription during development and in disease states. As such, it is critical for researchers to gain a good understanding of the relationship between the structure of various families of transcription factors and their function, as well as roles in human disease. Since publication of the Fourth Edition, there have been major advances, notably in the areas of chromatin remodeling and genome-scale analyses. This complete update includes all new coverage of the latest developments, from enabling genomic technologies to studies on the importance of post-translational modifications beyond phosphorylation events. Brand new coverage in this edition includes: * Potential of transcription factors as therapeutic targets in human disease * Importance of histone modifications * Use of genome-based sequence analysis and high-throughput methods * Applications of the chromatin immunoprecipitation (ChIP) assay * Transcriptional elongation * Regulation by post-translational modifications * Regulatory networks and bioinformatics.
|
| 505 |
0 |
|
|a DNA sequences, transcription factors and chromatin structure; Methods for studying transcription factors; RNA polymerases and the basal transcriptional complex; Families of DNA binding transcription factors; Activation of gene expression by transcription factors; Repression of gene expression by transcription factors; Regulation of transcription factor synthesis; Regulation of transcription factor activity; Transcription factors and human disease.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 590 |
|
|
|a Elsevier
|b ScienceDirect All Books.
|
| 650 |
|
0 |
|a Transcription factors.
|
| 650 |
|
0 |
|a Genetic transcription
|x Regulation.
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Molecular Biology.
|2 bisacsh.
|
| 650 |
|
7 |
|a Genetic transcription
|x Regulation.
|2 fast.
|
| 650 |
|
7 |
|a Transcription factors.
|2 fast.
|
| 650 |
|
2 |
|a Eukaryotic Cells.
|
| 650 |
|
2 |
|a Gene Expression Regulation.
|
| 650 |
|
2 |
|a Transcription Factors.
|
| 650 |
|
2 |
|a Transcription, Genetic.
|
| 650 |
|
7 |
|a Eukaryoten.
|2 gnd.
|
| 650 |
|
7 |
|a Transkription.
|2 gnd.
|
| 655 |
|
4 |
|a Electronic books.
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|a Latchman, David S.
|t Eukaryotic transcription factors.
|b 5th ed.
|d Amsterdam ; Boston : Elsevier/Academic Press, 2008
|z 9780123739834
|z 0123739837
|w (DLC) 2008270213
|w (OCoLC)156811844.
|
| 907 |
|
|
|a .b49808850
|b multi
|c -
|d 160302
|e 230104
|
| 998 |
|
|
|a cue
|a cu
|b 180626
|c m
|d z
|e -
|f eng
|g ne
|h 0
|i 2
|
| 948 |
|
|
|a MARCIVE Comp, in 2023.01
|
| 948 |
|
|
|a MARCIVE Comp, 2019.12
|
| 948 |
|
|
|a MARCIVE Q2, 2018
|
| 948 |
|
|
|a MARCIVE Comp, 2018.05
|
| 948 |
|
|
|a MARCIVE August, 2017
|
| 948 |
|
|
|a MARCIVE extract Aug 5, 2017
|
| 994 |
|
|
|a 92
|b COM
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2023.01
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2019.12
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2018.08
|
| 995 |
0 |
0 |
|a OCLC offline update by CMU and loaded with m2btab.elec in 2018.06
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2018.06
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2017.09
|
| 995 |
|
|
|a Loaded with m2btab.netlib2 in 2016
|
| 989 |
|
|
|d cueme
|e - -
|f - -
|g j
|h 0
|i 0
|j 188
|k 180626
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w Elsevier
|1 .i119613451
|u http://ezproxy.coloradomesa.edu/login?url=https://www.sciencedirect.com/science/book/9780123739834
|3 Elsevier
|z Click here for access
|